Company Selected - Sumitomo Dainippon Pharma Co Ltd - Income Statement
| Fiscal Year is From April To March - All Figures are in , Thousands, Except for the Diluted EPS Figure | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | View Chart |
|---|---|---|---|---|---|
| 416,159,000 | 398,832,000 | 372,713,000 | 342,665,000 | ||
| 162,600,000 | 153,437,000 | 147,153,000 | 138,581,000 | ||
| 162,600,000 | 153,437,000 | 137,648,000 | 119,475,000 | ||
| 0.0 | 0.0 | 9,505,000 | 19,106,000 | ||
| 253,559,000 | 245,395,000 | 225,560,000 | 204,084,000 | ||
| 201,608,000 | 216,607,000 | 448,799,000 | 479,975,000 | ||
| - | - | 206,147,000.00 | 263,661,000.00 | ||
| 44,916,000 | 49,865,000 | 75,729,000 | 88,553,000 | ||
| 156,692,000 | 166,742,000 | 166,923,000 | 127,761,000 | ||
| 51,951,000 | 28,788,000 | -223,239,000 | -275,891,000 | ||
| - | - | 19,191,000.00 | 1,374,000.00 | ||
Hid Interest Expense | 55,304,760 | 48,276,760 | 42,368,760 | 44,793,000 | |
Hid Interest Income | - | - | 20,734,000.00 | 20,734,000.00 | |
| -55,304,760 | -48,276,760 | -40,825,760 | -25,433,000 | ||
| -39,611,000 | -11,177,000 | 29,342,000 | -23,502,000 | ||
| 12,340,000 | 17,611,000 | -193,897,000 | -299,393,000 | ||
| -6,565,000 | -6,024,000 | -17,887,000 | -19,972,000 | ||
| 18,903,000 | 23,634,000 | -176,042,000 | -279,457,000 | ||
Hid [-] Net Income | 18,903,000 | 23,634,000 | -176,042,000 | -279,457,000 | |
| 18,905,000 | 23,635,000 | -176,010,000 | -279,421,000 | ||
HidHidHid Net Income From Continuing Ops | - | - | -197,230,000.00 | -247,193,000.00 | |
HidHidHid Discontinued Operations | - | - | - | - | |
HidHid Minority Interest Expense | 2,000 | 1,000 | 32,000 | 36,000 | |
| 0.0 | 0.0 | 0.0 | 0.0 | ||
| 47.58 | 59.49 | -443.11 | -703.41 | ||
| 397,290 | 397,290 | 397,290 | 397,290 | ||
| 39,844,000 | 39,791,000 | -172,688,000 | -221,805,000 | ||
| 15,986,000 | 14,229,000 | -201,948,000 | -254,600,000 |